Quoin Pharmaceuticals
QNRX
2 hedge funds and large institutions have $24K invested in Quoin Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 0 reducing their positions, and 4 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
50% less funds holding
Funds holding: 4 → 2 (-2)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
70% less capital invested
Capital invested by funds: $81.1K → $24K (-$57K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$19.6K |
| 2 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$4.32K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$70K |
| 2 |
Renaissance Technologies
New York
|
-$7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$3.12K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
-$951 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $19.7K | +$19.6K | +95 | New |
|
|
2
RhumbLine Advisers
Boston,
Massachusetts
| $4.33K | +$4.32K | +21 | New |
|
|
HNB
3
Huntington National Bank
Columbus,
Ohio
| $6 | – | – | – |
|
|
VF
4
Virtu Financial
New York
| – | -$70K | -352 | Closed |
|
|
5
Renaissance Technologies
New York
| – | -$7K | -33 | Closed |
|
|
6
UBS Group
Zurich,
Switzerland
| – | -$3.12K | -16 | Closed |
|
|
ASN
7
Advisory Services Network
Atlanta,
Georgia
| – | -$951 | -5 | Closed |
|
QNRX Hedge Fund Activity: Q2 2023 in Review
2 of the 6,371 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q2 2023, worth a combined $24K — down 70% from $81.1K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of QNRX and 2 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $19.6K. The largest seller was Virtu Financial, exiting entirely with an estimated $70K sold.
- 2 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q2 2023, down from 4 in Q1 2023.
- Funds reported $24K of Quoin Pharmaceuticals stock for Q2 2023, down 70% quarter-over-quarter.
- 2 funds opened new Quoin Pharmaceuticals positions in Q2 2023 and 4 closed out, a net change of -2 holders.
- The largest Quoin Pharmaceuticals buyer in Q2 2023 was Susquehanna International Group, an estimated $19.6K added.
- The largest Quoin Pharmaceuticals seller in Q2 2023 was Virtu Financial, an estimated $70K sold.
Based on aggregated 13F filings for Q2 2023.